Impact of rice based oral rehydration solution on stool output and duration of diarrhoea

Meta-analysis of 13 clinical trials

Sheila M. Gore, Olivier Fontaine, Nathaniel F. Pierce

Research output: Contribution to journalArticle

Abstract

Objective - To define the benefit of rice oral rehydration salts solution in relation to the glucose based World Health Organisation oral rehydration salts solution for treating and preventing dehydration in patients with severe dehydrating diarrhoea. Design-Meta-analysis using data from 13 available randomised trials that compared these two formulations. Subjects-The studies compared 1367 patients with cholera, severe cholera-like diarrhoea, or acute non-cholera diarrhoea. 668 received the standard WHO solution and 699 the rice based solution. Intervention - Each trial report was reviewed to determine patient eligibility, the number of patients who were randomised and the number of these excluded from analysis, details of the randomisation procedure, and the precise timing of the outcome measurements. Main outcome measures - Stool output during the first 24 hours; weighted estimates of the difference in mean stool output between treatments. Results - The rice solution significantly reduced the rate of stool output during the first 24 hours by 36% (95% confidence interval 28 to 44%) in adults with cholera and by 32% (19 to 45%) in children with cholera. The rate of stool loss in infants and children with acute non-cholera diarrhoea was reduced by only 18% (6 to 30%). Conclusions - The benefit of rice oral rehydration salts solution for patients with cholera is sufficiently great to warrant its use in such patients. The benefit is considerably smaller for children with acute, noncholera diarrhoea and should be more precisely defined before its practical value can be judged.

Original languageEnglish (US)
Pages (from-to)287-291
Number of pages5
JournalBMJ (Online)
Volume304
Issue number6822
StatePublished - Feb 1 1992
Externally publishedYes

Fingerprint

Rehydration Solutions
Fluid Therapy
Cholera
Meta-Analysis
Diarrhea
Clinical Trials
Salts
Random Allocation
Dehydration
Oryza
Outcome Assessment (Health Care)
Confidence Intervals
Glucose

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Impact of rice based oral rehydration solution on stool output and duration of diarrhoea : Meta-analysis of 13 clinical trials. / Gore, Sheila M.; Fontaine, Olivier; Pierce, Nathaniel F.

In: BMJ (Online), Vol. 304, No. 6822, 01.02.1992, p. 287-291.

Research output: Contribution to journalArticle

Gore, Sheila M. ; Fontaine, Olivier ; Pierce, Nathaniel F. / Impact of rice based oral rehydration solution on stool output and duration of diarrhoea : Meta-analysis of 13 clinical trials. In: BMJ (Online). 1992 ; Vol. 304, No. 6822. pp. 287-291.
@article{e135b40de61a4ec18e1c60544e03ef4d,
title = "Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: Meta-analysis of 13 clinical trials",
abstract = "Objective - To define the benefit of rice oral rehydration salts solution in relation to the glucose based World Health Organisation oral rehydration salts solution for treating and preventing dehydration in patients with severe dehydrating diarrhoea. Design-Meta-analysis using data from 13 available randomised trials that compared these two formulations. Subjects-The studies compared 1367 patients with cholera, severe cholera-like diarrhoea, or acute non-cholera diarrhoea. 668 received the standard WHO solution and 699 the rice based solution. Intervention - Each trial report was reviewed to determine patient eligibility, the number of patients who were randomised and the number of these excluded from analysis, details of the randomisation procedure, and the precise timing of the outcome measurements. Main outcome measures - Stool output during the first 24 hours; weighted estimates of the difference in mean stool output between treatments. Results - The rice solution significantly reduced the rate of stool output during the first 24 hours by 36{\%} (95{\%} confidence interval 28 to 44{\%}) in adults with cholera and by 32{\%} (19 to 45{\%}) in children with cholera. The rate of stool loss in infants and children with acute non-cholera diarrhoea was reduced by only 18{\%} (6 to 30{\%}). Conclusions - The benefit of rice oral rehydration salts solution for patients with cholera is sufficiently great to warrant its use in such patients. The benefit is considerably smaller for children with acute, noncholera diarrhoea and should be more precisely defined before its practical value can be judged.",
author = "Gore, {Sheila M.} and Olivier Fontaine and Pierce, {Nathaniel F.}",
year = "1992",
month = "2",
day = "1",
language = "English (US)",
volume = "304",
pages = "287--291",
journal = "British Medical Journal",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "6822",

}

TY - JOUR

T1 - Impact of rice based oral rehydration solution on stool output and duration of diarrhoea

T2 - Meta-analysis of 13 clinical trials

AU - Gore, Sheila M.

AU - Fontaine, Olivier

AU - Pierce, Nathaniel F.

PY - 1992/2/1

Y1 - 1992/2/1

N2 - Objective - To define the benefit of rice oral rehydration salts solution in relation to the glucose based World Health Organisation oral rehydration salts solution for treating and preventing dehydration in patients with severe dehydrating diarrhoea. Design-Meta-analysis using data from 13 available randomised trials that compared these two formulations. Subjects-The studies compared 1367 patients with cholera, severe cholera-like diarrhoea, or acute non-cholera diarrhoea. 668 received the standard WHO solution and 699 the rice based solution. Intervention - Each trial report was reviewed to determine patient eligibility, the number of patients who were randomised and the number of these excluded from analysis, details of the randomisation procedure, and the precise timing of the outcome measurements. Main outcome measures - Stool output during the first 24 hours; weighted estimates of the difference in mean stool output between treatments. Results - The rice solution significantly reduced the rate of stool output during the first 24 hours by 36% (95% confidence interval 28 to 44%) in adults with cholera and by 32% (19 to 45%) in children with cholera. The rate of stool loss in infants and children with acute non-cholera diarrhoea was reduced by only 18% (6 to 30%). Conclusions - The benefit of rice oral rehydration salts solution for patients with cholera is sufficiently great to warrant its use in such patients. The benefit is considerably smaller for children with acute, noncholera diarrhoea and should be more precisely defined before its practical value can be judged.

AB - Objective - To define the benefit of rice oral rehydration salts solution in relation to the glucose based World Health Organisation oral rehydration salts solution for treating and preventing dehydration in patients with severe dehydrating diarrhoea. Design-Meta-analysis using data from 13 available randomised trials that compared these two formulations. Subjects-The studies compared 1367 patients with cholera, severe cholera-like diarrhoea, or acute non-cholera diarrhoea. 668 received the standard WHO solution and 699 the rice based solution. Intervention - Each trial report was reviewed to determine patient eligibility, the number of patients who were randomised and the number of these excluded from analysis, details of the randomisation procedure, and the precise timing of the outcome measurements. Main outcome measures - Stool output during the first 24 hours; weighted estimates of the difference in mean stool output between treatments. Results - The rice solution significantly reduced the rate of stool output during the first 24 hours by 36% (95% confidence interval 28 to 44%) in adults with cholera and by 32% (19 to 45%) in children with cholera. The rate of stool loss in infants and children with acute non-cholera diarrhoea was reduced by only 18% (6 to 30%). Conclusions - The benefit of rice oral rehydration salts solution for patients with cholera is sufficiently great to warrant its use in such patients. The benefit is considerably smaller for children with acute, noncholera diarrhoea and should be more precisely defined before its practical value can be judged.

UR - http://www.scopus.com/inward/record.url?scp=0026531521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026531521&partnerID=8YFLogxK

M3 - Article

VL - 304

SP - 287

EP - 291

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-8146

IS - 6822

ER -